Concepedia

Sheila Sunga

SS

3

Publications

515

Citations

3

H-Index

2009

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sheila Sunga is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).

Publications per year

2009–2017

3

Publications

3

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

Thomas Seck, Michael A. Nauck, Sheila Sunga et al. · International Journal of Clinical Practice · 2010 · 202 citations

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji et al. · Diabetes Obesity and Metabolism · 2017 · 158 citations · Full text

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Pablo Aschner, H. L. Katzeff, Hongquan Guo et al. · Diabetes Obesity and Metabolism · 2009 · 155 citations · Full text

Rows per page

1–3 of 3